Qol Holdings Co., Ltd. (3034) Fiscal Year Ending March 2027 Q2 (Interim) Financial Summary

Summary of Results

For the cumulative consolidated interim period, revenue was 145,808 hundred million yen (YoY +2.5%), EBITDA was 15,544 hundred million yen (YoY +30.4%), operating income was 10,369 hundred million yen (YoY +44.4%), ordinary income was 10,353 hundred million yen (YoY +42.7%), and interim net income attributable to owners of parent was 4,675 hundred million yen (YoY +31.8%). All segments—pharmacies, BPO, and pharmaceuticals—contributed, and overall profit levels improved.

Outlook and Dividends

The full-year forecast is revenue of 315,000 hundred million yen, EBITDA of 28,700 hundred million yen, operating income of 16,500 hundred million yen, ordinary income of 16,500 hundred million yen, and net income attributable to owners of parent of 7,800 hundred million yen (earnings per share 209.45 yen). The most recently announced dividend forecast has been revised, including an increase in the interim dividend. Over the long term, the company will continue to provide information to investors through supplemental interim materials and earnings briefings.